1-5 of 5
Eric D. Bischoff
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment

Free
Nicola J. Clegg, John Wongvipat, James D. Joseph, Chris Tran, Samedy Ouk, Anna Dilhas, Yu Chen, Kate Grillot, Eric D. Bischoff, Ling Cai, Anna Aparicio, Steven Dorow, Vivek Arora, Gang Shao, Jing Qian, Hong Zhao, Guangbin Yang, Chunyan Cao, John Sensintaffar, Teresa Wasielewska, Mark R. Herbert, Celine Bonnefous, Beatrice Darimont, Howard I. Scher, Peter Smith-Jones, Mark Klang, Nicholas D. Smith, Elisa De Stanchina, Nian Wu, Ouathek Ouerfelli, Peter J. Rix, Richard A. Heyman, Michael E. Jung, Charles L. Sawyers, Jeffrey H. Hager
Journal: Cancer Research
Cancer Res (2012) 72 (6): 1494–1503.
https://doi.org/10.1158/0008-5472.CAN-11-3948
Published: 14 March 2012
View article titled, ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
Open the PDF for ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment in another window
Includes: Supplementary data
Journal Articles

Induction of Adipocyte-specific Gene Expression Is Correlated with Mammary Tumor Regression by the Retinoid X Receptor-Ligand LGD1069 (Targretin)

Free
Veena R. Agarwal, Eric D. Bischoff, Thomas Hermann, William W. Lamph
Journal: Cancer Research
Cancer Res (2000) 60 (21): 6033–6038.
Published: 01 November 2000
View article titled, Induction of Adipocyte-specific Gene Expression Is Correlated with Mammary Tumor Regression by the Retinoid X Receptor-Ligand LGD1069 (Targretin)
Open the PDF for Induction of Adipocyte-specific Gene Expression Is Correlated with Mammary Tumor Regression by the Retinoid X Receptor-Ligand LGD1069 (Targretin) in another window
Journal Articles

Beyond Tamoxifen: The Retinoid X Receptor-selective Ligand LGD1069 (TARGRETIN) Causes Complete Regression of Mammary Carcinoma

Free
Eric D. Bischoff, Marco M. Gottardis, Thomas E. Moon, Richard A. Heyman, William W. Lamph
Journal: Cancer Research
Cancer Res (1998) 58 (3): 479–484.
Published: 01 February 1998
View article titled, Beyond Tamoxifen: The Retinoid X Receptor-selective Ligand LGD1069 (TARGRETIN) Causes Complete Regression of Mammary Carcinoma
Open the PDF for Beyond Tamoxifen: The Retinoid X Receptor-selective Ligand LGD1069 (TARGRETIN) Causes Complete Regression of Mammary Carcinoma in another window
Journal Articles

A Novel Retinoic Acid Receptor-selective Retinoid, ALRT1550, Has Potent Antitumor Activity against Human Oral Squamous Carcinoma Xenografts in Nude Mice

Free
David R. Shalinsky, Eric D. Bischoff, William W. Lamph, Lin Zhang, Marcus F. Boehm, Peter J. A. Davies, Alex M. Nadzan, Richard A. Heyman
Journal: Cancer Research
Cancer Res (1997) 57 (1): 162–168.
Published: 01 January 1997
View article titled, A Novel Retinoic Acid Receptor-selective Retinoid, ALRT1550, Has Potent Antitumor Activity against Human Oral Squamous Carcinoma Xenografts in Nude Mice
Open the PDF for A Novel Retinoic Acid Receptor-selective Retinoid, ALRT1550, Has Potent Antitumor Activity against Human Oral Squamous Carcinoma Xenografts in Nude Mice in another window
Journal Articles

Chemoprevention of Mammary Carcinoma by LGD1069 (Targretin): An RXR-selective Ligand

Free
Marco M. Gottardis, Eric D. Bischoff, Michael A. Shirley, Murriel A. Wagoner, William W. Lamph, Richard A. Heyman
Journal: Cancer Research
Cancer Res (1996) 56 (24): 5566–5570.
Published: 01 December 1996
View article titled, Chemoprevention of Mammary Carcinoma by LGD1069 (Targretin): An RXR-selective Ligand
Open the PDF for Chemoprevention of Mammary Carcinoma by LGD1069 (Targretin): An RXR-selective Ligand in another window